Providing Formulation Development and Analytical Services for a range of pharmaceutical dosage forms, Penn's team have expertise in developing products with modified release characteristics and in successfully formulating poorly soluble molecules. Penn's development resources are co-located and integrated with our clinical trial supply capability.
Integrated with our Pharmaceutical Development service, Penn's flexible resources provide Manufacturing and Packing of Solid Oral Dose, Oral Liquids and Topicals for both Investigational and Commercial use. Penn has specific expertise in High Containment Operations for processing Highly Potents and we supply a broad portfolio of Orphan drugs and Oncology therapies.
Using our knowledge of regulatory guidelines backed by one of the strongest QP teams in the industry, Penn is the trusted partner for EU product testing and release. Our modern and efficient warehousing operation covers ambient and cool chain conditions and supports EU importation and global distribution.
Following the recent announcement from Penn Pharma on a new £14m high containment facility for production of tablets and capsules containing highly potent actives, the specialist provider of pharmaceutical development and manufacturing services, has today announced additional investment in its packing capacity and capabilities.
Penn Pharma, the specialist provider of pharmaceutical development and manufacturing services, is further driving the expansion of its UK operations with a strategic appointment to its Executive Team of Jerome Detreille as Senior Director of New Business Development. Jerome’s appointment comes after Penn Pharma recently announced a £14 million investment in its South Wales, UK facility to expand its specialist high containment facilities. Jerome’s role will be integral to the success of the new facility, due to open in January 2013.
Using our knowledge of Pharmaceutical Development, Clinical Trials and Commercial Supply, Penn has become the trusted supply partner of many of the top healthcare companies during our 30 years of trading.
We are rightly proud of our reputation for providing quality, flexible and reliable services which have been recognised by the UK Government and our clients in USA, Japan and Europe.
Our mission is to become the partner of choice, for the development, testing and supply of pharmaceuticals requiring the highest standards of GMP facilities backed by an enviable team of development scientists and supply chain professionals.